Article
The development of multiple reaction monitoring assays for liver-derived plasma.
2007-12-01
Abstract excerpt
There is wide interpatient variability in toxicity to chemotherapeutic drugs and a lack of routine clinical tests for prospectively identifying patients at risk of developing toxicity from chemotherapy. An empirically driven MS strategy has been developed to monitor liver-derived plasma proteins as potential biomarkers of early toxicity. Multiple reaction monitoring (MRM) has been used to assess 46 candidate pepti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f5268b5f-a986-545c-b02a-797ed6a0076e
- DOI
- 10.1002/prca.200700305
